American Journal of Reproductive Immunology
© John Wiley & Sons A/S
Edited By: Gil Mor
Impact Factor: 3.05
ISI Journal Citation Reports © Ranking: 2011: 10/28 (Reproductive Biology); 65/139 (Immunology)
Online ISSN: 1600-0897
NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement
Please read carefully. Failure to conform to standards outlined here may delay processing.
1. Online Submission - click here to submit your manuscript
2. The journal publishes information covering the area of reproductive immunology.
3. The journal is now operating an electronic editorial office. It is therefore recommended that manuscripts are submitted online via http://mc.manuscriptcentral.com/ajri. Detailed instructions and advice are available on the ScholarOne Manuscripts website. The manuscript must include a structured abstract, references, figures, legends, and tables. Please use the assigned reference number in correspondence. Submission of a manuscript will automatically represent that the authors have appropriate authorization from laboratory directors, department chairs, and/or grantees if such authorization is required. Submission is representation that the manuscript has not been published previously and is not currently under consideration for publication elsewhere. All submitted manuscripts must be accompanied by a completed Copyright Transfer Agreement (licensing copyright to Wiley-Blackwell).
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:
CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp
For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.
American Journal of Reproductive Immunology employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.
OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article.
With OnlineOpen, the author, the author's funding agency, or the author’s institution pays a fee to ensure that the article is made available to
non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see http://wileyonlinelibrary.com/onlineopen
Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website.
Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.
The work shall not be published elsewhere in any language without the written consent of the publisher. The articles published in this journal are protected by copyright, which covers translation rights and the exclusive right to reproduce and distribute all of the articles printed in the journal. No material published in the journal may be stored on microfilm or videocassette or in electronic databases or reproduced photographically without the prior written permission of the publisher. A covering letter should clearly identify the person (with address, fax, telephone numbers, and e-mail address) responsible for correspondence. Author(s) must also suggest three possible reviewers and mention any person(s) who may have a conflict of interest if requested to review the paper. If no conflict of interest exists, please explicitly state this in the covering letter. Failure to suggest three reviewers will delay processing.
4. Order the elements comprising the manuscript as follows: title page, abstract, key words, introduction, materials and methods, results, discussion, conclusions, appendix, acknowledgments, references, tables and figure-captions list.
5. Categories of publication: The following types of articles will be considered for publication. Authors are advised that submissions exceeding the length guidelines provided below will be returned unreviewed:
(1) Research Articles: reports of original, basic, clinical, translational studies relating to Reproductive Immunology. The reports should be well documented, novel, and significant. Research articles are published an average of 40 days after their final acceptance. The length restrictions for this category of publication are as follows: Text limit of 5000 words excluding references.
(2) Cutting-Edge report: Short, definitive reports of highly significant and timely findings. Priority Reports receive an accelerated review. Papers submitted as Priority Reports should contain Materials and Methods and Results and Discussions sections. The length of the whole manuscript is 2500 words, 10 references, no keywords, 2 figures and abstract is 100 words.
(3) Reviews: Articles that review a timely subject important to reproductive immunologist researchers. Reviews must be written as concisely as possible. All Review Articles, whether or invited or not, will be subject to peer review. Text limit of 3000 words.
(4) Public Issues: Brief articles (2000 words or less) on topics of interest to scientist involved in the areas of reproduction and immunology and the general public. These topics include articles on funding projects in Reproductive Immunology from the government, foundations; clinical application or directions of the progress in the field of immunology and reproduction; relations, training in the field, public or science education.
(5) Letters to the Editor and Opinion: The Editors invite the submission of correspondence that presents considered opinions in response to articles published in the journal or meeting presentations. Letters to the Editor will be peer reviewed and, if found to meet the requisite publication criteria the Letter may be sent to the author(s) of the originally published article and possibly to other interested parties for a response to be published in the same issue of the journal as the Letter.
(6) Meeting Reports: Brief reports of the Annual meetings of the Societies for Reproductive Immunology or special symposiums. (2000 words)
(7) Technical Reports: The objective of Technical Reports is to describe primary research data on a new technique that is likely to be influential in the field of reproductive immunology. Technical Reports have a format broadly similar to that of Original Manuscripts, though many Technical Reports are shorter than a typical Article. Technical Reports include a short abstract (typically 150 words) followed by separate sections for Introduction, Material and Methods and a combined Results and Discussion section. There is no strict limit on the number of display items. If statistical testing was used to analyze the data, the Methods section must contain a subsection on statistical analysis. References are normally limited to 10, but this can be flexible at the editor's discretion.Technical Reports may be accompanied by supplementary information. Technical Reports are peer reviewed, and authors must provide a competing financial interests statement before publication.
6. Title page - This should include the title of the article, authors' names (with degrees) and affiliations, complete mailing addresses, fax and telephone numbers of one author who will review the proofs, and suggested running head. The running head should be less than 45 characters (including spaces) and should indicate either diagnosis or major features of the case.
7. Abstract - This should be page two of the manuscript (2). It should be structured and consist of no more than 150 words, organized into four paragraphs, labeled Problem, Method of Study, Results and Conclusions.
8. Key words - A list of 3-6 key words is to be provided directly below the abstract. Key words should express the precise content of the manuscript and consist of words or phrases not in the title, as they are used for indexing purposes, both internal and external. They should each be arranged in alphabetical order and separated by a comma (,).
9. Acknowledgments - All acknowledgments (including those for grant and financial support) should be typed in one separate paragraph that directly precedes the reference section. The inclusion of individuals and/or of institutions in the acknowledgment section in a manuscript requires a signed approval from each individual mentioned in the acknowledgment and/or of an authorized individual representing the institution(s) that clearly states that the individual(s) and/or institution(s) agree to be named in an acknowledgment section of the paper. Illustrations from other publications must be acknowledged. Include the following when applicable: author(s), title of journal or book, volume number, page(s), month and year.
10. References - References are identified in the text by superscript figures. All references cited in the text should be typed double-spaced in a separate section at the end of the paper and numbered consecutively in the order in which they are cited in the text. Once a reference is cited, all subsequent citations should be to the original number. Abbreviations should conform to those in Index Medicus. We recommend the use of a tool such as Reference Manager for reference management and formatting.
Reference Manager reference styles can be searched for here:
1. Glass RH, Ericsson RJ: Intrauterine insemination of isolated motile sperm. Fertil Steril 1978;29:535-539.
2. Leigh H, Reiser MF: The Patient. New York, Plenum Medical, 1980.
Contribution to a book:
3. Shapiro BM: Awakening of the invertebrate egg at fertilization. In Fertilization and Embryonic Development in Vitro, L Mastroianni Jr., JD Biggers (eds). New York, Plenum Press, 1981, pp 233-255.
11. Tables - Tables should be typed on separate sheets, and numbered consecutively with Roman numerals. Tables should be self explanatory and include a brief descriptive title. Tables can be submitted as Excel or MS Word files.
12. Illustrations/Figures - Three sets of unmounted and untrimmed photographs, drawings, diagrams and/or charts are to be submitted, each in a separate labeled envelope. Illustrations should preferably be in the proportion of 12.5 x 18 cm (5 x 7 inch). Write the title of the paper, the name of the first author and set number (Set 1 of 3, etc.) on each of the envelopes.
Each figure is to be numbered in the consecutive series of Arabic numerals in the order in which it is cited in the text. Write the title of your paper, the name of the first author and the figure number on an adhesive label, which should be pasted on the back of each figure.On the label also indicate clearly the top margin of each figure.
Illustrations in full color are accepted for publication if the editors believe that color will add significantly to the published manuscript. Digital artwork for reproduction should preferably be submitted as EPS, TIFF or high-resolution JPEG files and meet our standards, but we may also be able to use other formats so please include these (see http://authorservices.wiley.com/submit_illust.asp )
13. Legends: Legends should be double-spaced, beginning on a separate sheet of paper. They should be numbered with Arabic numerals and referred to in the text. Maximum length should be limited to 100 words.
14. The journal requires that investigations performed in the United States on human subjects have the prior approval of the appropriate institutional committee on human experimentation.
15. Rapid Publication - Concise manuscripts (4 or fewer journal pages) representing studies of outstanding scientific significance may be submitted for Rapid Publication. These manuscripts must be completely documented by reference to the literature and by a thorough description of the experimental procedures. If authors desire Rapid Publication, they must state so explicitly in their covering letter. For more information regarding guidelines for Rapid Publication, please contact the Central Editorial Office.
16. Short Communications - Short Communications are concise manuscripts of two or less journal pages which represent not more than 10 double-spaced manuscript pages inclusive of figures, tables, and references. Authors must state explicitly in the covering letter that the paper is a Short Communication.
17. All measurements must be given in metric units. English units may also be given parenthetically if the measurements were originally done in English units. These guidelines are in accordance with the 'Uniform Requirements for Manuscripts Submitted to Biomedical Journals'.
18. Proofs: The corresponding author will receive an email alert containing a link to a web site. A working e-mail address must therefore be provided for the corresponding author. The proof can be downloaded as a PDF (portable document format) file from this site. Acrobat Reader will be required in order to read this file. This software can be downloaded (free of charge) from the following web site: http://www.adobe.com/products/acrobat/readstep2.html.
This will enable the file to be opened, read on screen and printed out in order for any corrections to be added. Further instructions will be sent with the proof. Hard copy proofs will be posted if no e-mail address is available.
- One original and two copies of manuscript
- Individual figures labeled and separated into 3 labeled envelopes
- Diskette labeled with the first named author and title of manuscript
- Structured abstract: maximum length 150 words
- Format of the manuscript conforms to those outlined in 'Instructions for Authors'. Pay particular attention to the references.
NEW: Online production tracking is now available for your article through Wiley-Blackwell’s Author Services.
Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production so they don’t need to contact the production editor to check on progress. Visit http://authorservices.wiley.com/bauthor/ for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
The American Journal of Reproductive Immunology is covered by Wiley-Blackwell's Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles means that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article.
The Publisher, the American Society for Reproductive Immunology and Editors cannot be held responsible for errors or any consequences arising from the use of information contained in the this journal; the views and opinions expressed do not necessarily reflect those of the Publisher, the American Society for Reproductive Immunology and Editors, neither does the publication of advertisments constitute any endorsement by the Pulisher, the American Society for Reproductive Immunology and Editors of the products advertised.
NEITHER MANUSCRIPTS NOR FIGURES WILL BE RETURNED AFTER REVIEW.